Piramal Enterprises | PEL | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2017
2018
2019
2020
2021
Revenue
Revenue
85,468106,394132,153130,683131,730
Cost of revenue
Cost of revenue
-14,442-15,267-15,292-16,768-19,216
Gross Profit
Gross Profit
71,026
91,127
116,861
113,915
112,514
Sales, general & ad...
Sales, general and administrative
-36,034-39,528-45,915-32,494-34,136
Depreciation
Depreciation and amortization
-3,817-4,773-5,202-5,203-5,609
Provision
Provision
0000-99
Other op inc/exp...
Other operating income/expenses
000-18,7470
Operating income
Operating income EBIT
31,174
46,825
65,745
57,471
72,670
 
      
Profit before tax
Profit before tax
13,10319,63820,1199,17631,173
Net Income
Net income
12,520
51,215
14,731
240
13,323
 
 
 
 
 
 
 
EPS Basic
EPS Basic in Rupees
72.56
281.76
74.16
1.14
56.19